Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.
Journal: ACS medicinal chemistry letters
Published: May 11, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology.
Journal: Bioorganic & medicinal chemistry letters
Published: February 22, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026